ANZGOG held its 17th Annual Scientific Meeting (ASM) in Brisbane, 22-24 March 2023.

The ANZGOG ASM 2023 proved to be an outstanding success with 324 delegates from Australia and New Zealand converging at the Hilton Hotel in Brisbane, QLD last week. The conference provided an excellent platform for engaging in meaningful discussions and collaborative efforts in the field of gynaecological oncology research.

The Hilton Grand Ballroom was a buzz with energy and enthusiasm as members delved into the latest pre-clinical, translational and clinical trial research, treatment practices, equity and survivorship issues presented by the leading experts in the field.

The conference kicked off with a variety of workshops supporting early career researchers, scientists, radiation oncologist, consumers, gynae-onc nurses and study coordinators. A workshop for the rare gestational trophoblastic disease (GTD) proved popular .

The welcome reception provided a wonderful opportunity for connecting with both long-term collaborators and friends, in addition to many new faces from diverse specialties! Thank you to all the poster presenters who covered a holistic range of research aspects including psychological, epigenetic and registry studies, drug repurposing, and emerging technologies associated with personalised treatment.


We are thrilled to announce the following winners of the abstract poster and oral presentations from last weeks conference. They were scored on the significance and innovation of their research, clarity of their results, the relevance of their research in the gynaecological oncology space and the quality of their presentation. A huge congratulations to these deserving winners!

  • Pre-clinical Abstract Award – Bonnita Werner
  • Clinical Abstract Award – Alison Brand AM
  • Pre-clinical Poster Award – Dongli Liu
  • Clinical Poster Award – Tanya Ross

2023 ANZGOG Awards

It is with great excitement that we announce the winners of the 2023 ANZGOG Awards which recognises the efforts of five remarkable individuals in improving outcomes for women diagnosed with gynaecological cancer.

These individuals have made a significant impact on this field through their tireless work, innovative research and unwavering commitment. We extend a heartfelt thank you to each of the winners and look forward to the continued impact of their work.

  • Michael Friedlander AM Award – Dr Nikki Burdett 
  • Research Pioneer Award – Professor David Bowtell 
  • ANZGOG Chair’s Community Volunteer Award – Duncan McPherson OAM
  • Clinical Trial Achievement Award – Professor Linda Mileshkin
  • Outstanding Clinical Trial Site Award – Newcastle Private Trials Unit

Read more about the winners and their contributions.


Delegates were provided with truly thought-provoking and insightful keynote addresses delivered by our esteemed international speakers that broadly encapsulated advancements made in treating gynaecological cancers, from a historical perspective to recent developments.

International Keynote Presentations:

Prof René Pareja (Gynaecological Oncologist, Columbia). “History doesn’t repeat itself but it does rhyme: the tale of cervical cancer surgery.”

Dr Ina Jürgenliemk-Schulz (Radiation Oncologist, Netherlands). “Recent key advancements in locally advanced cervical cancer: A Radiation Oncologist’s View.”

Prof Iain McNeish (Medical Oncologist, United Kingdom). “The key advances and major setbacks in treating gynaecological cancers in the past five years.”

“Thank you to all that attended ANZGOG 2023. Such a pleasure to be surrounded by friends again. A very special mention to our dazzling international speakers Prof Rene Pareja, Dr Ina Jürgenliemk-Schulz and Prof Iain McNeish who updated us on the key advances in gynaecological cancers.Together with our fabulous national speakers we were spoilt with a wealth of information, updated on our clinical trials and experienced a fabulous 3 days of all things ANZGOG!”

Dr Michelle Harrison
Chair | ASM 2023 Program Steering Committee

Translational research, including molecular profiling techniques and best practice recommendations featured strongly, as the implications on risk and treatment response become increasingly apparent.

Other presentation highlights included the Engaging with Culturally and Linguistically Diverse (CALD) Communities session, which generated an active Q&A panel discussion. An interactive, polling Tumour Board session was thought-provoking.

A presentation on time management for clinician researchers was a particularly apt conclusion to the program given the incredible breadth of research and obvious dedication of all attendees, experienced over the course of the conference.

A huge thank you again goes out to Dr Michelle Harrison and A/Prof Yoland Antill, Chair and Deputy Chair respectively of the ASM 2023 Program Steering Committee and each of the Steering Committee members who gave their time and commitment to organize this dynamic conference program.

We are excited to announce upcoming reviews of the ASM in Oncology News and Research Review in the next few weeks, which will feature the key highlights and presentations from the conference. Keep an eye out for it!


Discover the world of PARP inhibitors in this informative video featuring Prof. David Bowtell, co-Head of the Women’s Cancer Program at the Peter MacCallum Cancer delves into the science behind PARP inhibitors and their role in revolutionizing ovarian cancer treatment.